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Key role of T cell defects in age-related
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Clayton A. Wiley,6 and Janko Nikolich-Žugich1,2,4,5
and Gene Therapy Institute and 2Oregon National Primate Research Center, Oregon Health & Science University,
Beaverton, OR 97006
3Department of Microbiology, Washington University, St. Louis, MO 63110
4Department of Immunobiology and 5Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ, 85724
6Department of Pathology, University of Pittsburgh College of Medicine, Pittsburgh, PA 15213

West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that becomes increasingly more prevalent over the age of 50 and is 40–50× more prevalent in
people over the age of 70, compared with adults under the age of 40. In a mouse model of
age-related vulnerability to WNV, we demonstrate that death correlates with increased
viral titers in the brain and that this loss of virus control with age was the result of defects
in the CD4 and CD8 T cell response against WNV. Specific age-related defects in T cell
responses against dominant WNV epitopes were detected at the level of cytokine and lytic
granule production, each of which are essential for resistance against WNV, and in the
ability to generate multifunctional anti-WNV effector T cells, which are believed to be
critical for robust antiviral immunity. In contrast, at the peak of the response, old and adult
T cells exhibited superimposable peptide sensitivity. Most importantly, although the adult
CD4 or CD8 T cells readily protected immunodeficient mice upon adoptive transfer, old T
cells of either subset were unable to provide WNV-specific protection. Consistent with a
profound qualitative and quantitative defect in T cell immunity, old brains contained at
least 12× fewer total effector CD8 T cells compared with adult mice at the peak of brain
infection. These findings identify potential targets for immunomodulation and treatment to
combat lethal WNV infection in the elderly.

CORRESPONDENCE
Janko Nikolich-Žugich:
nikolich@email.arizona.edu
Abbreviations used: GzB, granzyme B; IFNAR, IFN-␣␤
receptor; MST, mean survival
time; WNV, West Nile virus.

West Nile virus (WNV) is a small enveloped
single-stranded positive sense RNA-containing
virus with a genome of ⵑ11 Kb that belongs to
the family flaviviridae (Lindenbach and Rice,
2001). WNV is a typical arbovirus, cycling between its two natural hosts, mosquitoes and
birds (Hayes, 2001). Mosquitoes transmit WNV
to a wide range of other species (including humans), which cannot further spread the infection (dead-end hosts) but which, nevertheless,
can exhibit significant morbidity and mortality.
Since 1999, this virus has been responsible for
>23,000 clinically registered human infections,
leading to nearly 1,000 deaths in the United
States alone (http://www.cdc.gov/ncidod/
dvbid/westnile/surv&control.htm). Moreover,
annual outbreaks in the United States have
been registered in every year since 2000 and
were marked by increased mortality rate in infected birds (Anderson et al., 1999) and horses
(Ng et al., 2003) and by an increase in the fre-
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quency and clinical severity of WNV infection
within the human population (Petersen and
Marfin, 2002). These observations are consistent with findings elsewhere in the world since
the mid 1990s (Tsai et al., 1998; Chowers et al.,
2001; Platonov et al., 2001) and suggest that the
US strains of WNV may exhibit an increase in
virulence compared with the original old-world
strains of WNV.
The incidence of WNV infection is fairly
uniform with age (Mostashari et al., 2001) and, in
most immunocompetent humans, the disease is
asymptomatic (Weiss et al., 2001; Petersen and
Marfin, 2002). However, severe WNV disease,
which includes the involvement of the nervous
system (meningitis and encephalitis), is a disease
of old age, with a frequency of ⵑ1 in 150, a
© 2009 Brien et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months
after the publication date (see http://www.jem.org/misc/terms.shtml). After six
months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons
.org/licenses/by-nc-sa/3.0/).
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1Vaccine

RESULTS
Mouse model of age-related susceptibility to WNV
We established a robust mouse model of the age-related susceptibility to WNV. In our hands, old mice exhibited increased susceptibility to WNV regardless of the infection route (i.p. or s.c.),
the viral isolate of WNV Ia (NY-99, 31A, or 385–99; Table S1,
Fig. 1; see Figs. 2 and 5; and not depicted), or the mouse strain
(Fig. 1, C57BL/6; and see Figs. 2 and 5, C57BL/6; or Fig. S1,
BALB/c) used, although, as expected, i.p infection produced lethal effects at a lower dose (1–20 PFU) compared with the more
physiological s.c. infection (50–1,000 PFU). Overall, old mice
were at least six times more susceptible to WNV as measured by
survival rates over many viral concentrations (Fig. 1 A and not
depicted). At low viral doses, that difference was drastically reduced and, in some experiments, disappeared (Fig. 1 A, Table
S1, and not depicted), whereas at the high doses both old and
adult animals succumbed to infection, suggesting that the viral
dose is one of the principal determinants of selective mortality of
old mice within a specific dose window.
2736

In principle, this age-related susceptibility could be the
result of a generalized inability of old mice to control the
virus at the level of both the innate and adaptive immune
systems, of the generalized inability to control the virus by
one of these two components, or of their focused inability to
control the virus in selected target organs. To investigate this
issue, infectious viral titer was determined in different organs
of adult and old mice and at different time points after infection. After infection with a viral dose that kills most old but
not adult mice, we found no significant difference in viral titers between adult and old mice between days 2 and 5 (Fig. 1 B
and Fig. S2). Likewise, early time points showed no difference in spleen viral titers (Fig. S2), and our survey of other
organs (kidney, gut and liver) also failed to show viral titer
differences between old and adult animals between days 3
and 10. We could not detect WNV in the blood past day 5
or in any other organs past day 10, and certain organs (lung
and skin, except the site of injection) were negative throughout the course of infection, with the exception of the central
nervous system. Indeed, we found significantly higher viral
titers in the brains of old mice compared with the adult counterparts on days 8 and 10 after infection (actually between
days 7 and 12 [not depicted]; Fig. 1 C, left and middle). Two
additional lines of evidence showed that viral titers within the
brain directly correlated to mortality. First, once the animals
became moribund, they exhibited equivalent and high brain
WNV titers regardless of age (Fig. 1 B, right). Moreover,
when higher infection doses of WNV, lethal to both adult
and old mice, were used, both adult and old mice again exhibited comparable and high brain viral titers (unpublished data).
Therefore, in all subsequent experiments where we sought to
dissect the immunological basis of vulnerability to WNV, we
used the viral doses at which most old animals had high viral
titers in brain and died but at which the majority of adult
mice exhibited low brain WNV titers and survived.
Relative kinetics and roles of innate and adaptive immune
responses in mediating defense against WNV infection
We next asked whether the differences mentioned in the
previous section could be explained by age-related defects in
innate or adaptive immunity. As a model of pronounced innate immunity defect, we used IFN-␣␤ receptor (IFNAR)–
deficient mice (IFNAR⫺/⫺; Müller et al., 1994), which are
unable to respond to type I IFNs (IFN-I) and are known to
be highly susceptible to numerous infections (for review see
Pestka et al., 2004), including WNV (Samuel and Diamond,
2005). Rag-1⫺/⫺ mice (Mombaerts et al., 1992), which have
no T and B cells as a result of the lack of the recombinase essential for generation of T and B cell receptors and which are
also susceptible to many infections, including WNV (Engle
and Diamond, 2003), were used as a model of profoundly
deficient adaptive immunity. Our results confirmed that both
of these strains are highly susceptible to WNV (Fig. 2 A) but
highlighted a difference in the mean survival times (MSTs;
Fig. 2 A). Thus, IFNAR⫺/⫺ mice died rapidly after infection
(MST, 5 d), which is consistent with the lack of innate defensive
T cell defects and age-related vulnerability to WNV | Brien et al.
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lethality of 10%, and a mean age at death of 78 yr (Mostashari
et al., 2001; Murray et al., 2006). Persons between 50 and 59 yr
of age exhibit a 10× higher incidence of severe WNV disease, whereas persons aged 80 yr or older exhibit a 43×
higher incidence, compared with the adults between 20 and
40 yr of age (Nash et al., 2001; Murray et al., 2006). Moreover, many patients that suffer from WNV encephalitis require more than one and, possibly, several years to fully
recover physically, functionally, and cognitively (Weiss et al.,
2001), and the overall mortality in the first year after infection is significantly increased compared with age-matched
controls (Murray et al., 2006).
Aging leads to a widespread but poorly understood state
of immunodeficiency, which is associated with an increased
incidence and severity of infectious disease in the elderly
(Gardner, 1980). Many facets of innate and adaptive immunity have been shown to be altered by aging (Cambier, 2005;
for reviews see Miller, 1996; Pawelec et al., 1998; Linton and
Dorshkind, 2004), but at the present it is unclear which of
these defects are critical to impaired immune defense. It is
further unclear whether the critical age-related defects are
constant or whether they vary depending on the biology of
the encountered pathogen. It is of note that T cells have been
shown to exhibit some of the most pronounced age-related
defects (for reviews see Miller, 1996; Nikolich-Žugich, 2005),
and reversion of T cell defects has been associated with improved immune function in old rodents and monkeys (Garcia
and Miller, 2003; Haynes et al., 2004, 2005; Messaoudi et al.,
2006). However, direct mechanistic links between a decline
in T cell function and reduced immune defense against infectious diseases remain scarce. Therefore, we examined the immunological basis of the age-related increase in susceptibility
to WNV, and we report in this paper that qualitative and
quantitative impairment with age in effector T cell immunity
at the site of critical affected tissue (the brain) leads to increased susceptibility to this virus.

Ar ticle

adult spleen cells, as well as the adult T cells, conferred significant protection to RAG1⫺/⫺ mice. In contrast, mice that received old cells were afforded weaker protection, which was
not improved in the case of splenocytes and was significant for
transferred old T cells (P < 0.04) compared with RAG1⫺/⫺
mice receiving no cell transfer. Direct comparison between
the protective capacity of adult and old T cells revealed significantly better protection by adult T cells (P < 0.003; Fig. 2 B).
Because antigen presentation and priming are not affected by
either age or by the targeted deletion of Rag-1 in the adult
RAG1⫺/⫺ mice, these results collectively strongly suggested that
the process of aging impairs resistance to WNV at the level of
generation of primary T cell responses.
Age-related differences in WNV-specific T cell responses
IgM and the virus-specific CD8 and CD4 T cells were all implicated in affording protection against WNV in adult mice
(Diamond et al., 2003; Shrestha and Diamond, 2004; Sitati
and Diamond, 2006). Given the extensive literature on the
decline of T cell immunity with aging and our results with
T cell transfers, we initiated experiments to test possible defects
in the T cell pool. We first examined signs of T cell activation

Figure 1. Age-related susceptibility to WNV disease in old mice. (A) Survival of adult (4–6 mo old) and old (18–22 mo old) mice after challenge
with the indicated doses of WNV 385–99 s.c. or i.p. Old mice are five and six times more susceptible to WNV upon i.p. (MST, 13 d) and s.c. (MST, 14 d) infection, respectively, compared with adult controls. Statistical significance was evaluated by the Log-rank test (***, P < 0.0005; *, P < 0.05). Please note
that difference between the old and adult mice disappears at the high viral challenge dose, where essentially all animals succumb to infection, and also at
the low virus dose, where old animals appear to control the low viral loads well (left; see also Table S1 for additional experiments with other viral isolates
and routes). Results depict mortality (n = 12 mice/group) and are representative of at least four experiments with similar results. (B and C) Viral titers
within indicated tissues and organs of adult and old mice after s.c. infection (1,200 PFU/mouse) were determined by quantitative PCR (B, whole blood
expressed in approximate PFU equivalents, based on quantitative PCR of a known WNV RNA standard) or by plaque assay (C, brain). The brains of old mice
contained significantly more virus on both day 7 and day 10 after infection. In contrast, there was no difference between brain viral levels of old and
adult moribund mice on day 12–16. For data on day 3 blood and spleen by plaque assay, please see Fig. S2. Horizontal bars indicate mean values of the
unpaired Student’s t test. Error bars represent SEM.
JEM VOL. 206, November 23, 2009
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mechanisms, whereas the RAG1⫺/⫺ mice died within the
same temporal window as old and adult mice (MST, 13 d).
Because the MST of old mice was 13–14 d, we concluded
that innate immunity in these mice, unlike that in IFNAR⫺/⫺
animals, was capable of containing the virus and fending off
early WNV-mediated mortality. Therefore, any putative defects in innate immunity in old mice, if present, do not lead
to early loss of viral control. To confirm this, we examined
functional levels of IFN-I in the serum of adult and old animals. Although the results of this test cannot be taken as fully
conclusive because of the low sensitivity of this assay (Fig. S3),
we detected no major age-related differences within these
confines. More importantly, any defect in innate immunity
would have been expected to result in loss of viral control
early after infection. However, this was not observed in any
of the experiments designed to test early viremia and viral
spread (Fig. 1 and Fig. S2).
Because the results suggested a key role for defects in adaptive immunity, we directly explored this possibility by performing adoptive transfers of old and adult spleen cells (Fig. 2 B,
left) or T cells (CD4 and CD8; Fig. 2 B, right) into adult
RAG1⫺/⫺ mice. In this series of experiments, we found that

also making the cytokine (Fig. 3 C). That suggested the existence of superimposed qualitative defects in immunity of old
mice against WNV.
To analyze the quality of the anti-WNV response in
depth, we examined several aspects of the response, including
the ability to produce polyfunctional cells, the intensity of
cytokine expression/cell, the level of activation of CD8 cells
as measured by CD43 expression, and the ability to lyse peptide-coated cells (Fig. 4). By each and every measure, old
CD8 T cells were significantly inferior to the adult counterparts. Thus, although nearly 40% of adult CD8 cells expressed
IFN-␥, TNF, and GzB (Fig. 4 A, 3 Fxn), only 21% of adult
cells did so. Second, expression of each of these molecules
per cell was significantly lower in old CD8 T cells (Fig. 4 B).
Third, only about half of the WNV-specific (Tet+) CD8 T
cells from old mice expressed high levels of CD43, an important activation and function marker (Fig. 4 C). Finally, direct
ex vivo cytotoxicity correlated to GzB expression and was

Figure 2. Relative roles of innate and adaptive immunity and the importance of the age of T cells in resistance to WNV infection. (A) IFNAR⫺/⫺, RAG1⫺/⫺, and WT mice were infected with the indicated WNV doses s.c., and MST and percentage of survival were scored. WNV caused rapid
mortality (MST, 4.5 d at 200 PFU) with a very low rate of survival in IFNAR⫺/⫺ mice compared with WT controls (P < 0.0001 at 200 PFU). WNV infection
also caused significant mortality in RAG-1⫺/⫺ mice compared with WT controls (P < 0.0001) but MST was similar to that of WT mice (MST, 13 d at 200
PFU). Data were compiled from two independent experiments. (B) Adoptive transfer of lymphocytes from old and adult mice reveals age-related defects
in adaptive immunity. Splenocytes (107/animal) from adult mice protect RAG-1⫺/⫺ significantly better than splenocytes from old mice (top; MST, 14.5 at
100 PFU; P = 0.0025). Transfer of purified T cells (CD4 and CD8; 5 × 106/mouse) reveals defects in old T cells, which were inferior at protecting RAG1⫺/⫺
mice compared with the purified T cells from adult mice (bottom; 100 PFU; P < 0.03). Compared with RAG1⫺/⫺ mice with no transfer, old splenocytes
conferred no significant protection, whereas old T cells showed some protection (P = 0.04). **, P = 0.01–0.001; ***, P < 0.001. Results are representative of
two comparable experiments.
2738
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using multicolor flow cytofluorometric analysis. We followed
quantitative and qualitative aspects of antigen-specific responses
using peptide MHC class I tetramers, as well as the functional
response measured by the ability to produce IFN-␥, TNF, and
granzyme B (GzB) and express CD43, a molecule involved in
T cell activation, costimulation, and effector function (Onami
et al., 2002), and to perform lytic function in response to recently identified immunodominant WNV peptide epitopes
that stimulate CD8+(Brien et al., 2007) and CD4+ T cells
(Brien et al., 2008; Figs. 3 and 4). At the peak of the response
(days 7–8 after infection), we detected a strongly significant
reduction in both percentages and numbers of CD8+ cells
specific for the immunodominant class I–restricted epitope
NS4b2488 by both tetramer staining (Fig. 3 A) and IFN-␥ production after brief in vitro stimulation (Fig. 3 B). In addition to
these quantitative defects, the ratio between IFN-␥–producing
and NS4b2488 Tet+ cells was also significantly reduced in old
CD8 cells so that less than one-half of Ag-specific cells were

Ar ticle

Mechanisms of T cell–mediated protection against WNV
disease and their failure in old mice
We next wanted to determine whether the observed reduction in IFN-␥ secretion and/or GzB expression were

relevant for protection against WNV in vivo. To that
effect, we performed two types of adoptive transfer experiments using RAG1⫺/⫺ mice as recipients. First, we
transferred total T cells from WT, IFN-␥⫺/⫺, or perforin⫺/⫺
donors into RAG1⫺/⫺ recipients, which showed that T
cells defective in IFN-␥ or perforin provide negligible, if
any, protection as compared with animals which received
no cells at all (Fig. 5 A). This confirms and extends prior
results on the importance of these molecules in anti-WNV
protection (Engle and Diamond, 2003; Wang et al., 2003)
and stresses the critical role of their expression in T cells.
However, because old T cells have a reduction but not a
complete absence of these molecules, we tested their antiviral ability in vivo by separately transferring highly purified (< 0.5% cross-contamination) CD4 and CD8 T cells
from old or adult naive donors into adult RAG1⫺/⫺ recipients. These results convincingly showed that either adult
CD4 or adult CD8 T cells were sufficient to confer significant protection to RAG1⫺/⫺ mice against primary WNV
infection in the absence of other components of the adaptive immune system (Fig. 5 B). More importantly, neither
the CD4+ nor the CD8+ T cells from the old mice were
able to confer any protection upon RAG1⫺/⫺ mice over
the level seen in the absence of transfer (Fig. 5 B), although the combination of the two old T cell subsets did
show some synergy, affording a low level of protection
(Fig. 2 B, bottom).

Figure 3. Functional quantitative defects in T cell activation in response to WNV infection. Infection was as in Fig. 1 A. (A) CD8+ T cells derived
from spleens of old and adult mice were harvested on day 8 and analyzed for the proportion (left and middle left, representative examples; middle right,
aggregate analysis of relative numbers) and absolute numbers (right, absolute numbers) of cells expressing the CD8+ NS4b-2488:Kb+ phenotype. Dots
denote individual mice (n = 8) and are representative of four experiments. (B) Same as A, except that measurements show relative representation and
absolute numbers of CD8+ IFN-␥+ cells in response to the immunodominant NS4b-2488 CD8 epitope by ICCS (Brien et al., 2007) at the peak of the immune response (day 8). Old mice mobilized significantly fewer numbers of IFN-␥–producing WNV-specific CD8+ T cells than their adult counterparts.
Results were compiled from three independent experiments. (C) Ratio between IFN-␥+ and Tet+ CD8+ cells shows that many fewer Ag-specific T cells are
functionally able to manufacture this cytokine in the old mice. Groups, representation, and graphics are as in A, and results are representative of two
experiments. Horizontal bars indicate mean values of the unpaired Student’s t test. Error bars represent SEM.
JEM VOL. 206, November 23, 2009

2739

Downloaded from https://rupress.org/jem/article-pdf/206/12/2735/814073/jem_20090222.pdf by Washington University In St. Louis Libraries user on 21 December 2019

essentially nonexistent in CD8 T cells from old mice compared with adult counterparts (Fig. 4 D).
These findings were consistent in every experiment performed. Sometimes not all the parameters would reach statistical significance when smaller animal groups were used, but
at least three out of four observations were always significant.
Similarly, these trends and significant differences were confirmed with the CD8 epitope ENV347 and also in CD4+ cells
using the immunodominant CD4+ T cell epitopes (ENV641
and NS31616+2066) by measuring frequency and magnitude of
the IFN-␥ (Fig. S4) and other responses (not depicted). Based
on the prior descriptions of signaling defects in CD4 T cells
(Garcia and Miller, 2003; for review see Miller, 1996), we
expected that some of the stated problems in old T cells may
trace to inferior ability of old T cells to process antigenic stimulus. However, experiments examining peptide sensitivity of
WNV-specific CD8 and CD4 T cells showed superimposable
sensitivity of old and adult cells at the peak of the response
(Fig. S5). We conclude that old mice exhibit profound quantitative and qualitative defects in mobilizing fully developed
effector T cells but that these defects do not extend to all aspects of antigen recognition and activation.

mice, like in the adult animals, CD3+ cells readily infiltrated the brain parenchyma on days 7 (not depicted) and
12 (Fig. 6 A), suggesting that there was no major difference
in migration and homing. In contrast, the composition of
the infiltrate was both qualitatively and quantitatively different (Fig. 6, B and C). The large (activated) mononuclear
cell gate (Fig. 6 B) contained nearly 3× fewer cells in old
mice compared with adult counterparts (3.1 vs. 9.1%, P <
0.0005). Moreover, within that gate, the percentage of
CD4 and CD8 cells was also about twofold lower with
old age (5.6 vs. 11.4%, P < 0.013, and 14.1 vs. 24.3%,

Figure 4. Quality of WNV-specific responses in old mice is impaired at several levels. For all panels, animals were infected with 1,000 PFU WNV
385–99 and were analyzed on day 8, unless otherwise indicated. (A) At the peak of infection, splenic CD8 cells were stimulated with class I–restricted
peptides and analyzed for the expression of IFN-␥, TNF, and GzB, and results were plotted to denote percentages of cells exhibiting all three molecules
(3 Fxn), two molecules (2 Fxn), or a single molecule (1 Fxn). Results depict eight animals per group and are representative of two such experiments. (B) Relative intensity of expression of IFN-␥, TNF, and GzB among CD8+ cells in response to 6 h of NS4b-2488 peptide stimulation as described in Materials and
methods. After gating on CD8+ T cells, normalized mean fluorescent intensity (MFI) was obtained by subtracting the mean fluorescent intensity of the
negative cell population from that of the positive cells. Data depict five adult and six old individual mice, representative of four experiments, and are
shown as in Fig. 1 A. (C) Expression of CD43 on WNV-specific CD8 cells from adult and old mice was analyzed on day 8 after infection by selective gating
and is expressed as percentage of Tet+CD8+ cells that are CD43+, shown for eight animals per group and representative of three such experiments. Horizontal bars in B and C indicate mean values of the unpaired Student’s t test. (D) Ex vivo cytotoxic activity of adult and old CD8+ T cells demonstrates major age-related functional defects. Adult and old mice were infected s.c. with WNV at a dose (1,000 PFU) that caused decreased survival of old mice
compared with adult animals. CD8+ T cells from adult mice exhibited stronger cytotoxic activity than CD8+ T cells from old mice when assayed directly ex
vivo 7 d after infection in a 6-h standard 51Cr-release assay. Peptide-coated NS4b2488 (10⫺6M) EL-4 cells were used as targets. Values for five mice per
group with standard deviations, representative of two experiments, are shown. P-values are depicted above the graphs.
2740

T cell defects and age-related vulnerability to WNV | Brien et al.

Downloaded from https://rupress.org/jem/article-pdf/206/12/2735/814073/jem_20090222.pdf by Washington University In St. Louis Libraries user on 21 December 2019

Too little and too weak: insufficient numbers
of ineffective effector T cells accumulate in the brains
of WNV-infected old mice
If our conclusions were correct, we would expect that they
would hold at the level of key organs targeted by WNV.
Alternatively, it was also possible that there may be defects
in migration and localization of virus-specific T cells to the
old brain. To address this issue, we examined the localization and composition of leukocyte infiltrate in the brains
of WNV-infected old and adult mice. It is of interest that
immunohistochemical examination revealed that in old
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CD8 T cells (Fig. 6 D) compared with adult brains at the
peak of infection.
Two important conclusions can be drawn from these results. First, migration to the site of major virus-induced tissue
damage is not drastically affected in T cells of old animals.
Second, although old T cells apparently arrived to the site of
infection, they were not able to differentiate into effector T
cells either systemically or locally in numbers sufficient to ensure control of neurovirulence. Therefore, our results identify defects in generation of sufficient number and quality of
effector antiviral T cells as the key phenomenon underlying
age-related susceptibility to WNV in this model, providing
targets for potential therapeutic manipulation.

Figure 5. Inability of aged CD4 and CD8 T cells to protect RAG-1ⴚ/ⴚ mice against lethal WNV infection. (A) Purified CD8 and CD4 T cells from
C57BL/6 (closed squares), IFN␥⫺/⫺ (open squares), or perforin⫺/⫺ (closed triangles) mice were transferred into RAG-1⫺/⫺ mice, which were then infected
with 200 PFU WNV and scored for survival. WT T cells exhibited significantly enhanced protection when compared with RAG-1⫺/⫺ mice with no transfer
(closed circles, P < 0.0006) or RAG-1⫺/⫺ mice receiving perforin⫺/⫺ (P < 0.003) or IFN-␥⫺/⫺ T cells (P < 0.01). (B) Young RAG-1⫺/⫺ mice received no cells
(closed diamonds) or received highly purified adult (squares) or old (inverted triangles) CD4 (closed symbols) or CD8 (open symbols) T cells (5 × 106 cells/
mouse). Engraftment was verified after 24 h, with animals infected with 200 PFU WNV, and survival was scored thereafter. Adoptive transfer of old CD4
or CD8 T cells failed to confer any protection to RAG-1–deficient hosts, whereas transfer of adult CD4 (P < 0.0001) or CD8 (P < 0.01) T cells afforded a
high degree of protection. Both parts of the figure were reproduced in three separate experiments.
JEM VOL. 206, November 23, 2009
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P < 0.037 for CD4 and CD8 cells, respectively; Fig. 6 C), leading to a >5× reduction in total CD8 and CD4 cells in old
WNV-infected brains. Among these already diminished
numbers, the content and quality of virus-specific cells was
further reduced. Therefore, the percentage of NS4b-specific tetramer+ CD8 cells specific for WNV was reduced by
another twofold (18.6 vs. 38.8%, P < 0.0012; Fig. 6 D),
with another reduction in GzB-producing cells (trend but
not significant at 3.3 vs. 6.7%, P < 0.06; not depicted).
Most importantly, when all the reductions were taken into
account, compared with the levels found in adult mice
(taken as 100%), our analysis suggests that old brains contain at least 12.5× fewer and up to 20× fewer Tet+ GzB+
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Figure 6. Analysis of brain infiltrates from WNV-infected adult and old mice. The brains of old and adult C57BL/6 mice were harvested 12 d after
infection with 1,000 PFU WNV 385–99 s.c., sectioned, and costained for CD3 (green) and WNV (red). (A) Representative adult (top) and old (bottom) brains
are shown at medium (left) and high (right) power. CD3 T cells are stained green and WNV-infected neurons are red. Bar: (left) 50 μm; (right) 20 μm.
(B) Brains of 10 old and 10 adult mice harvested 10 d after infection with WNV. To generate five independent samples per group, with sufficient cell
2742
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vent the block in lymphopoiesis and the stromal rejuvenation
using KGF, androgen blockade, or IL-7 treatment (for reviews see Linton and Dorshkind, 2004; Nikolich-Žugich,
2005) would appear to provide the best approach.
However, it will also be important to understand other,
perhaps more subtle, potential defects in innate and adaptive
immunity. Thus, although our results strongly suggest that
there are no major age-related defects in early virus control by
the innate immune system, they do not exclude the possibility
of correction of T cell defects by providing enhanced activation of innate immunity by cytokine manipulation (Haynes
et al., 1999, 2004) and/or antigen presentation. Indeed, such
approaches may provide more practical means for therapeutic
intervention compared with T cell rejuvenation, which still remains to be effectively customized for mass utilization. However,
one could imagine providing key cytokines or costimulatory
molecules in repeated rounds of antigen-driven T cell and
B cell expansion to enhance and improve effector T cell generation. It is our belief that such intervention may be most effective to remedy the defects described in this paper. Overall,
given the multitude of defects that affect an aging immune
system, it seems prudent to elucidate specific and key defects
affecting resistance to each pathogen and then rationally target
the identified defects for intervention.
MATERIALS AND METHODS
Mice. Old (18–22 mo) and adult (4–6 mo) C57BL/6 (B6) mice were purchased
from the National Institute of Aging breeding colony (Harlan). C57BL/6
RAG1⫺/⫺, 129, C57BL/6 perforin⫺/⫺, and C57BL/6 IFN-␥⫺/⫺ mice were
purchased from The Jackson Laboratory and bred at the Oregon Health & Science University (OHSU) West Campus vivarium. IFNAR⫺/⫺ mice were a gift
of A. Hill (OHSU, Beaverton, OR). All animals were housed and bred under
specific pathogen-free conditions at OHSU and experiments conducted under
the Institutional Animal Care and Use Committee and the Institutional Biosafety
Committee approvals in accordance with all applicable federal, state, and local
regulations. All WNV experiments were completed within a United States
Department of Agriculture (USDA)–inspected Biosafety Level three facility.
Virus, peptides, and cell lines. WNV strains NY99, 31A, and 385–99
were used and all virus strains yielded similar results. WNV strains NY99 and
385–99 were gifts of R. Tesh (University of Texas Medical Branch, Austin,
TX). Strain 31A was provided by the USDA. Peptides NS3 1616, NS3 2066,
and NS4b 2488-2496 (21st Century Biochemicals) were diluted in 10% H2O
and 90% DMSO and stored at ⫺80°C. Vero, MC57g, and EL-4 cell lines
were mycoplasma negative and were cultured under aseptic conditions with
DME (VERO and MC57g) or RPMI (EL-4) supplemented with antibiotics
and 5% fetal calf serum. MC57gs were infected using an MOI of 10 for 30 h
before use for 51Cr assays. MC57gs were infected using an MOI of 10 for
30 h before use for 51Cr assays.

numbers for analysis, pools of two brains each were made and cells isolated using percoll gradient. The representation of cells using mononuclear/lymphocyte
gate in representative adult (left) and old (middle) mice are shown. The aggregate analysis of cell percentages in this gate are shown on the right, illustrating that there are significantly fewer cells in the lymphocyte gate in old mice. Comparison is based on at least 5 × 105 collected events/sample.
(C) Representation (left) and aggregate analysis (right) of the percentage of CD4 and CD8 T cells within the brain of old versus adult mice as determined
by flow cytometry. Significant differences were seen in representation of these cell subsets as well. (D, left) Representation of CD8 NS4b-2488 tetramer+ T
cells among all CD8 T cells in the brains of old mice is further reduced compared with adults (P = 0.00372). (D, right) Illustration of cumulative effects of
reduced representation of total lymphocytes, CD8 cells, and CD8 NS4b-2488 Tet+/GrB+ T cells in the brains of old mice compared with adults (taken as
100%) reveal an ⵑ12× age-related difference. Experiment is representative of three independent experiments. Horizontal bars indicate mean values of
the unpaired Student’s t test. Error bars represent SEM.
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DISCUSSION
Our results show that specific age-related defects in T cell
immunity, affecting both CD8 and CD4 T cells, underlie the
susceptibility of old mice to WNV. This is in contrast to
some of the other viral infections, such as Vaccinia, where no
defects in GzB expression directly ex vivo can be detected
(unpublished data), or influenza, where there is no reproducible age related decrease in survival in mice (Bender et al.,
1995; Gardner, 2005) and where the loss of CD8 T cells was
not accompanied by impaired viral resistance (Eichelberger et
al., 1991), but it is similar to impaired lytic function of CD8
T cells against HSV-1 in old mice (Messaoudi et al., 2004).
Numerous innate (IFN-I, complement, and innate IgM antibody) and adaptive (B cells and CD4 and CD8 T cells) mechanisms were implicated in anti-WNV resistance in adult mice
(Diamond, 2005) but their relative importance and primary
roles still remain incompletely mapped. Our results show that
both T cell subsets play important and independent antiviral
roles in adult mice, although there is evidence that they could
also synergize (e.g., Fig. 2) against the virus. Adult CD4 and
CD8 T cells were both able to secrete IFN-␥ (results presented in this study) and to kill infected target cells (Brien et al.,
2007, 2008; Purtha et al., 2007), which are critically important anti-WNV effector mechanisms (Shrestha et al., 2006;
Sitati and Diamond, 2006; Fig. 5 A), and both functions were
impaired with aging (Figs. 3 and 4). Moreover, adult T cells
were polyfunctional and exhibited significantly more robust
per cell responses at the level of effector molecule mobilization but did not exhibit higher TCR sensitivity (Fig. 4, Fig. S4,
and Fig. S5). Of major importance are the results from adoptive transfers into RAG1⫺/⫺ mice, where adult, but not old,
CD4 or CD8 T cells could confer significant anti-WNV protection. Because these animals possess functional (and young)
innate and reticuloendothelial system components and only
lack B, T, and NK-T cells, our results reveal that the defects
in transferred aged T cells are cell autonomous in nature and
are not precipitated by the aging of accessory and/or antigenpresenting cells. Consistent with this finding, examination of
brain T cell infiltrates revealed normal migration in old mice
but insufficient accumulation of differentiated effector T cells,
which were 10–20× less numerous in the brains of old mice.
This would suggest that the use of T cell rejuvenation therapies to remedy this condition may offer the best chance for
therapeutic intervention. In this case, thymic reawakening
and production of additional cohorts of Ag-specific T cells by
the use of a combination of stem cell intervention to circum-

IFN-I bioassay. Serum levels of IFN-I were measured using a bioassay.
Type I IFN standards (National Institute of Allergy and Infectious Diseases
international standard) and experimental sample mouse serum were serially
diluted twofold down a flat-bottom 96-well tissue culture–treated plate in
complete media, 10% FBS, Pen/Strep, and DME. IFN-responsive L929 cells
were plated at 5 × 104 cells/well, incubated overnight with the serum, and
media aspirated, and media containing 5 PFU VSV Indiana was added to
each well, except for control wells. 24 h later, media was aspirated, the plate
washed twice with PBS, and the monolayer fixed with 5% formaldehyde,
incubated for 10 min, and stained with 0.05% crystal violet for 10 min.
Washed monolayers were allowed to dry, and 100% methanol was used to
elute the dye. Absorbance is measured at 595 nm on an ELISA plate reader
(Invitrogen). Experimental samples are compared with the standard curve to
determine endpoint values.
Infection and CTL analysis. Mice were infected i.p. with 0.16–20 PFU
of WNV virus or s.c. with 20–1,200 PFU per mouse as denoted in the figure
legends. At indicated times after infection, lymphocytes were isolated and
used for direct flow cytometry analysis, direct ex vivo restimulation for cytokine production, and direct ex vivo 51Cr assay. Percentage of specific lysis
was calculated as [(E⫺S)/(M⫺S)] × 100, where E equals the counts per
minute released from targets incubated with lymphocytes, S equals the
counts per minute released from target cells incubated with no lymphocytes,
and M equals the counts per minute released from cells after lysis with 1%
Nonidet P40 (Affymetrix).
Lymphocyte purification and adoptive transfer. Old and adult T cells
from corresponding mouse populations were enriched by positive selection
of CD4 and/or CD8 T cells using MACS separation (Miltenyi Biotec) in
accordance with manufacturer’s protocol. Purity of obtained cells was 90–
95% CD8+/CD4+ as determined by flow cytometry, and the opposite subset
and B cells were present at <0.5% in all transferred populations. 2–10 × 106
cells were injected i.v. and engraftment success was evaluated by flow cytometry 24 h later at the time of infection.
Survival experiments. Animals were challenged with no other manipulations or 24 h after cell transfer with indicated doses and routes of WNV.
Survival was scored on a daily basis. Death occurred between days 10 and 18,
and all animals surviving this period remained disease free for >60 d, at
which point the experiment was discontinued. Data are shown as percentage
of survival at the termination of the experiment.
Determination of viral burden. Animals were sacrificed and liver, spleen,
brain, and kidney were removed and homogenized in RPMI using a beadbeater-96 (BioSpec). Samples were spun at 2,000 rpm for 10 min at 4°C and
aliquots of each sample were stored at ⫺80°C. Viral titer was determined by
plaque assay by serially diluting sample onto Vero cells. After co-culture of
the virus with the cells for 2 h, agarose overlay was added. 2 d after the initial
overlay, cells were overlayed with additional agarose containing Neutral red
(0.2%). Plaques where then counted to determine viral load.
2744

Statistical analyses. Fisher’s exact test and Log-rank test were used to analyze
results from survival experiments. Statistical significance of viral titer observed
between groups was analyzed using a Mann Whitney U test. Other tests are as
indicated. All calculations were performed using Prism software (GraphPad
Software, Inc.).
Online supplemental material. Fig. S1 shows survival of adult and old
BALB/c mice infected with WNV. Fig. S2 shows viral titer in the organs of
adult and old mice at indicated days after administration of a WNV dose lethal to old but not adult mice. Fig. S3 shows IFN-I activity in the serum of
old and adult mice. Fig. S4 shows the response of adult and old CD4 T cells
to class II MHC-restricted WNV peptide epitopes. Fig. S5 shows that peptide sensitivity of 8-d-old and adult CD8 and CD4 T cells is largely superimposable. Table S1 shows that old mice exhibit increased WNV mortality
regardless of route of injection or viral isolate. Online supplemental material
is available at http://www.jem.org/cgi/content/full/jem.20090222/DC1.
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